Ultrahigh–dose rate FLASH radiotherapy (FLASH-RT) is a potentially paradigm-shifting
treatment modality that holds the promise of expanding the therapeutic index for nearly any …

Resistance to cancer therapy remains a major challenge in clinical oncology. Although the
initial treatment phase is often successful, eventual resistance, characterized by tumour …

As a new tumor treatment strategy, photothermal therapy (PTT) has the advantages of
accuracy, ease of administration, a high efficiency and low side effects. Photothermal …

In recent years, novel two-dimensional (2D) nanomaterials are of great interest for diverse
potential applications such as device fabrication, energy storage, sensing and theranostics …

Type I interferon is promising in treating different kinds of tumors, but has been limited by its
toxicity, lack of tumor targeting, and very short half-life. To target tumors, reduce systemic …

Radiation-induced chromosomal aberrations represent an early marker of late effects,
including cell killing and transformation. The measurement of cytogenetic damage in tissues …

Next‐generation cancer treatments are expected not only to target cancer cells but also to
simultaneously train immune cells to combat cancer while modulating the immune …

Despite their clinical success in drug delivery applications, the potential of theranostic
nanomedicines is hampered by mechanistic uncertainty and a lack of science-informed …

Radiation is a highly efficient therapy in squamous head and neck carcinoma (HNSCC)
treatment. However, local recurrence and metastasis are common complications. Recent …

Radiation is a mainstay of cancer therapy. Radioresistance is a significant challenge in the
treatment of locally advanced, recurrent and metastatic cancers. The mechanisms of …